Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner(University of Alabama at Birmingham), Paul M. Harari(University of Wisconsin–Madison), J. Giralt(Vall d'Hebron Hospital Universitari), Roger B. Cohen(Fox Chase Cancer Center), Christopher U. Jones, Ranjan Sur(Hamilton Regional Laboratory Medicine Program), David Raben(University of Colorado Denver), José Baselga(Vall d'Hebron Hospital Universitari), Sharon A. Spencer(University of Alabama at Birmingham), Junming Zhu, Hagop Youssoufian, Eric K. Rowinsky, K. Kian Ang(The University of Texas MD Anderson Cancer Center)
Cited by 1,971
Abstract
Related Papers
No related papers found
Powered by citation graph analysis